Report Detail

Request for Sample of this report

Pharma & Healthcare Global Recombinant Coagulation Factor IX Market Insights, Forecast to 2028

  • RnM4423211
    • |
  • 26 April, 2022
    • |
  • Global
    • |
  • 91 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Summary:

Market Analysis and Insights: Global Recombinant Coagulation Factor IX Market
Due to the COVID-19 pandemic, the global Recombinant Coagulation Factor IX market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 500 IU accounting for % of the Recombinant Coagulation Factor IX global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Adult segment is altered to an % CAGR throughout this forecast period.
China Recombinant Coagulation Factor IX market size is valued at US$ million in 2021, while the US and Europe Recombinant Coagulation Factor IX are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Recombinant Coagulation Factor IX landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Recombinant Coagulation Factor IX include Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics and Thermo Fisher, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
500 IU
1000 IU
Other
Segment by Application
Adult
Children
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Recombinant Coagulation Factor IX market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Rebinyn
CSL Behring
Takeda
Sanofi
Aptevo Bio Therapeutics
Thermo Fisher
Frequently Asked Questions
Which is the most lucrative product segment in the Recombinant Coagulation Factor IX market?
Which are the prominent strategies of the Recombinant Coagulation Factor IX market players?
Which factors are increasing the competition in the Recombinant Coagulation Factor IX market?
Which are the recommendations provided by the Recombinant Coagulation Factor IX industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Recombinant Coagulation Factor IX market growth?
Which product segment will register the fastest growth rate in the Recombinant Coagulation Factor IX market?
Which emerging trends will impact the Recombinant Coagulation Factor IX market growth?
Which are the high-impact rendering factors in the Recombinant Coagulation Factor IX market?
Which companies will maintain their lead on the Recombinant Coagulation Factor IX market?


Table of Contents

    1 Study Coverage

    • 1.1 Recombinant Coagulation Factor IX Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Recombinant Coagulation Factor IX Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 500 IU
      • 1.2.3 1000 IU
      • 1.2.4 Other
    • 1.3 Market by Application
      • 1.3.1 Global Recombinant Coagulation Factor IX Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Adult
      • 1.3.3 Children
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Recombinant Coagulation Factor IX Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Recombinant Coagulation Factor IX Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Recombinant Coagulation Factor IX Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Recombinant Coagulation Factor IX Sales by Region
      • 2.4.1 Global Recombinant Coagulation Factor IX Sales by Region (2017-2022)
      • 2.4.2 Global Sales Recombinant Coagulation Factor IX by Region (2023-2028)
    • 2.5 Global Recombinant Coagulation Factor IX Revenue by Region
      • 2.5.1 Global Recombinant Coagulation Factor IX Revenue by Region (2017-2022)
      • 2.5.2 Global Recombinant Coagulation Factor IX Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Recombinant Coagulation Factor IX Sales by Manufacturers
      • 3.1.1 Global Top Recombinant Coagulation Factor IX Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Recombinant Coagulation Factor IX Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Coagulation Factor IX in 2021
    • 3.2 Global Recombinant Coagulation Factor IX Revenue by Manufacturers
      • 3.2.1 Global Recombinant Coagulation Factor IX Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Recombinant Coagulation Factor IX Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factor IX Revenue in 2021
    • 3.3 Global Recombinant Coagulation Factor IX Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Recombinant Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Recombinant Coagulation Factor IX Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Recombinant Coagulation Factor IX Sales by Type
      • 4.1.1 Global Recombinant Coagulation Factor IX Historical Sales by Type (2017-2022)
      • 4.1.2 Global Recombinant Coagulation Factor IX Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Recombinant Coagulation Factor IX Sales Market Share by Type (2017-2028)
    • 4.2 Global Recombinant Coagulation Factor IX Revenue by Type
      • 4.2.1 Global Recombinant Coagulation Factor IX Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Recombinant Coagulation Factor IX Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2017-2028)
    • 4.3 Global Recombinant Coagulation Factor IX Price by Type
      • 4.3.1 Global Recombinant Coagulation Factor IX Price by Type (2017-2022)
      • 4.3.2 Global Recombinant Coagulation Factor IX Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Recombinant Coagulation Factor IX Sales by Application
      • 5.1.1 Global Recombinant Coagulation Factor IX Historical Sales by Application (2017-2022)
      • 5.1.2 Global Recombinant Coagulation Factor IX Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Recombinant Coagulation Factor IX Sales Market Share by Application (2017-2028)
    • 5.2 Global Recombinant Coagulation Factor IX Revenue by Application
      • 5.2.1 Global Recombinant Coagulation Factor IX Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Recombinant Coagulation Factor IX Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Recombinant Coagulation Factor IX Revenue Market Share by Application (2017-2028)
    • 5.3 Global Recombinant Coagulation Factor IX Price by Application
      • 5.3.1 Global Recombinant Coagulation Factor IX Price by Application (2017-2022)
      • 5.3.2 Global Recombinant Coagulation Factor IX Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Recombinant Coagulation Factor IX Market Size by Type
      • 6.1.1 North America Recombinant Coagulation Factor IX Sales by Type (2017-2028)
      • 6.1.2 North America Recombinant Coagulation Factor IX Revenue by Type (2017-2028)
    • 6.2 North America Recombinant Coagulation Factor IX Market Size by Application
      • 6.2.1 North America Recombinant Coagulation Factor IX Sales by Application (2017-2028)
      • 6.2.2 North America Recombinant Coagulation Factor IX Revenue by Application (2017-2028)
    • 6.3 North America Recombinant Coagulation Factor IX Market Size by Country
      • 6.3.1 North America Recombinant Coagulation Factor IX Sales by Country (2017-2028)
      • 6.3.2 North America Recombinant Coagulation Factor IX Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Recombinant Coagulation Factor IX Market Size by Type
      • 7.1.1 Europe Recombinant Coagulation Factor IX Sales by Type (2017-2028)
      • 7.1.2 Europe Recombinant Coagulation Factor IX Revenue by Type (2017-2028)
    • 7.2 Europe Recombinant Coagulation Factor IX Market Size by Application
      • 7.2.1 Europe Recombinant Coagulation Factor IX Sales by Application (2017-2028)
      • 7.2.2 Europe Recombinant Coagulation Factor IX Revenue by Application (2017-2028)
    • 7.3 Europe Recombinant Coagulation Factor IX Market Size by Country
      • 7.3.1 Europe Recombinant Coagulation Factor IX Sales by Country (2017-2028)
      • 7.3.2 Europe Recombinant Coagulation Factor IX Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Recombinant Coagulation Factor IX Market Size by Type
      • 8.1.1 Asia Pacific Recombinant Coagulation Factor IX Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Recombinant Coagulation Factor IX Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Recombinant Coagulation Factor IX Market Size by Application
      • 8.2.1 Asia Pacific Recombinant Coagulation Factor IX Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Recombinant Coagulation Factor IX Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Recombinant Coagulation Factor IX Market Size by Region
      • 8.3.1 Asia Pacific Recombinant Coagulation Factor IX Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Recombinant Coagulation Factor IX Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 China Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Recombinant Coagulation Factor IX Market Size by Type
      • 9.1.1 Latin America Recombinant Coagulation Factor IX Sales by Type (2017-2028)
      • 9.1.2 Latin America Recombinant Coagulation Factor IX Revenue by Type (2017-2028)
    • 9.2 Latin America Recombinant Coagulation Factor IX Market Size by Application
      • 9.2.1 Latin America Recombinant Coagulation Factor IX Sales by Application (2017-2028)
      • 9.2.2 Latin America Recombinant Coagulation Factor IX Revenue by Application (2017-2028)
    • 9.3 Latin America Recombinant Coagulation Factor IX Market Size by Country
      • 9.3.1 Latin America Recombinant Coagulation Factor IX Sales by Country (2017-2028)
      • 9.3.2 Latin America Recombinant Coagulation Factor IX Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina

    10 Middle East and Africa

    • 10.1 Middle East and Africa Recombinant Coagulation Factor IX Market Size by Type
      • 10.1.1 Middle East and Africa Recombinant Coagulation Factor IX Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Recombinant Coagulation Factor IX Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Recombinant Coagulation Factor IX Market Size by Application
      • 10.2.1 Middle East and Africa Recombinant Coagulation Factor IX Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Recombinant Coagulation Factor IX Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Recombinant Coagulation Factor IX Market Size by Country
      • 10.3.1 Middle East and Africa Recombinant Coagulation Factor IX Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Recombinant Coagulation Factor IX Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Corporation Information
      • 11.1.2 Pfizer Overview
      • 11.1.3 Pfizer Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 Pfizer Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 Pfizer Recent Developments
    • 11.2 Rebinyn
      • 11.2.1 Rebinyn Corporation Information
      • 11.2.2 Rebinyn Overview
      • 11.2.3 Rebinyn Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 Rebinyn Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 Rebinyn Recent Developments
    • 11.3 CSL Behring
      • 11.3.1 CSL Behring Corporation Information
      • 11.3.2 CSL Behring Overview
      • 11.3.3 CSL Behring Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 CSL Behring Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 CSL Behring Recent Developments
    • 11.4 Takeda
      • 11.4.1 Takeda Corporation Information
      • 11.4.2 Takeda Overview
      • 11.4.3 Takeda Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 Takeda Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 Takeda Recent Developments
    • 11.5 Sanofi
      • 11.5.1 Sanofi Corporation Information
      • 11.5.2 Sanofi Overview
      • 11.5.3 Sanofi Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 Sanofi Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 Sanofi Recent Developments
    • 11.6 Aptevo Bio Therapeutics
      • 11.6.1 Aptevo Bio Therapeutics Corporation Information
      • 11.6.2 Aptevo Bio Therapeutics Overview
      • 11.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 Aptevo Bio Therapeutics Recent Developments
    • 11.7 Thermo Fisher
      • 11.7.1 Thermo Fisher Corporation Information
      • 11.7.2 Thermo Fisher Overview
      • 11.7.3 Thermo Fisher Recombinant Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 Thermo Fisher Recombinant Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 Thermo Fisher Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Recombinant Coagulation Factor IX Industry Chain Analysis
    • 12.2 Recombinant Coagulation Factor IX Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Recombinant Coagulation Factor IX Production Mode & Process
    • 12.4 Recombinant Coagulation Factor IX Sales and Marketing
      • 12.4.1 Recombinant Coagulation Factor IX Sales Channels
      • 12.4.2 Recombinant Coagulation Factor IX Distributors
    • 12.5 Recombinant Coagulation Factor IX Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Recombinant Coagulation Factor IX Industry Trends
    • 13.2 Recombinant Coagulation Factor IX Market Drivers
    • 13.3 Recombinant Coagulation Factor IX Market Challenges
    • 13.4 Recombinant Coagulation Factor IX Market Restraints

    14 Key Findings in The Global Recombinant Coagulation Factor IX Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:
      Get latest Market Research Reports on Recombinant Coagulation Factor IX . Industry analysis & Market Report on Recombinant Coagulation Factor IX is a syndicated market report, published as Global Recombinant Coagulation Factor IX Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Recombinant Coagulation Factor IX market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$4,350.00
      		$8,700.00
      		3,480.00
      		6,960.00
      		4,062.90
      		8,125.80
      		687,039.00
      		1,374,078.00
      		362,920.50
      		725,841.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo